Live Quote · NASDAQARVNHealthcare· Biotechnology

Arvinas, Inc.

$6.46▼ 4.15%($-0.28)
MKT CAP $423.03MNEXT EARNINGS Feb 23, 2027
50%
Bullish
TickerSpark Score
56/100
▌ Mixed
80
Valuation
40
Profitability
60
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARVN research report →

Analyst Price Target
$12.00+85.8% vs. today

Range $10 – $14

Analyst RatingBuy
19 Buy6 Hold1 Sell

Price Chart

-41.38% · this period
$13.83$10.12$6.41Nov 20May 26Nov 20
52-Week Range2% of range
Low
$6.33
Current
$6.46
High
$14.51